Article Details
Retrieved on: 2024-03-19 13:57:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
David Risinger has given his Hold rating due to a combination of factors regarding Pfizer's ongoing and future projects. One of the primary ...
Article found on: markets.businessinsider.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here